Skip to main content
. 2009 Jan 14;20(1):87–94. doi: 10.1089/hum.2008.081

Table 1.

Helper-Dependent Vector Production

Vector Titer (particles/ml) Total yield (particles) Helper Contamination (PFU/ml) Lot used for infection
gAd.shFABP5-1 2.8 × 1011 7.7 × 1011 N/D  
gAd.shFABP5-2 5.2 × 1011 1.9 × 1012 N/D Lot 1
gAd.shFABP5-3 4.1 × 1011 1.4 × 1012 7.8 × 106 Lot 1
gAd.shFABP5-4 6.1 × 1011 1.8 × 1012 7.8 × 106 Lot 1
gAd.shFABP5-5 3.4 × 1011 9.4 × 1011 N/D Lot 3
gAd.shFABP5-8 7.4 × 1011 1.3 × 1012 N/D Lot 3
gAd.shFABP5-9 1.3 × 1012 4.1 × 1012 N/D Lot 8
gAd.shFABP5-10 7.2 × 1011 2.2 × 1012 N/D Lot 8
gAd.shSCR-1 6.7 × 1011 2.5 × 1012 8 × 108  
gAd.shSCR-2 8.6 × 1011 2.4 × 1012 8 × 108 Lot 1
gAd.shSCR-3 5.0 × 1011 1.7 × 1012 N/D Lot 1
gAd.shSCR-4 8.8 × 1011 3.5 × 1012 N/D Lot 1
gAd.shSCR-5 9.7 × 1011 2.4 × 1012 N/D Lot 4
gAd.shSCR-6a 5.0 × 1011 1.3 × 1012 N/D Lot 4
gAd.shSCR-12 7.4 × 1011 2.3 × 1012 N/D Lot 11
gAd.shSCR-13 6.9 × 1011 2.1 × 1012 N/D Lot 11
gAd.shSCR-14 5.8 × 1011 1.3 × 1012 N/D Lot 11
gAd.shLacZ-1 3.3 × 1011 1.3 × 1012 3.3 × 108  
gAd.shLacZ-2 5.6 × 1011 1.4 × 1012 2.6 × 107 Lot 1
gAd.shLacZ-3a 4.7 × 1011 8.0 × 1011 N/D Lot 2
gAd.shLacZ-5 7.4 × 1011 1.6 × 1012 4.5 × 107 Lot 2
gAd.shLacZ-6 4.6 × 1011 7.3 × 1011 4.5 × 107 Lot 2
gAd.shSREBP-1 6.655 × 1011 2.86 × 1012 N/D  
gAd.shSREBP-2 1.265 × 1012 4.048 × 1012 N/D Lot 1
gAd.shSREBP-3 7.205 × 1011 2.52 × 1012 N/D Lot 2
gAd.shSREBP-4 4.29 × 1011 1.54 × 1012 N/D Lot 3
gAd.H1shSREBP-1 3.5 × 1011 5.3 × 1012 3.2 × 107  
gAd.H1shSREBP-2 1.0 × 1012 3.0 × 1012 1.2 × 108 Lot 1
gAd.H1shSCR-1 3.1 × 1011 1.7 × 1012 7.8 × 107  
gAd.H1shSCR-2 1.6 × 1012 3.5 × 1012 1.1 × 109 Lot 1
gAd.Albmal1-1 2.5 × 1011 4.8 × 1011 N/D  
gAd.Albmal1-2 7.5 × 1011 2.6 × 1012 N/D Lot 1
gAd.Albmal1-3 1.7 × 1012 6.0 × 1012 N/D Lot 2

Abbreviation: N/D, not determined.

a

shRNA expression cassette from this preparation was sequenced.